Home Newsfeeds Oppenheimer Downgrades RingCentral to Perform

Oppenheimer Downgrades RingCentral to Perform

Oppenheimer analyst Timothy Horan downgrades RingCentral (NYSE:RNG) from Outperform to Perform.

byBenzinga Newsdesk

March 17, 2023

1 minute read

Oppenheimer analyst Timothy Horan downgrades RingCentral (NYSE:RNG) from Outperform to Perform.

Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling

By Avi Kapoor

April 16, 8:08 AM

The Nasdaq 100 closed lower by around 300 points on Monday. Investors, meanwhile, focused on some notable insider trades.

EVER

Barclays Initiates Coverage On KKR & Co with Overweight Rating, Announces Price Target of $69

By Benzinga Newsdesk

March 2, 6:29 AM

Barclays analyst Benjamin Budish initiates coverage on KKR & Co (NYSE:KKR) with a Overweight rating and announces Price Target of $69.

KKR

‘iPhone Gains China Market Share In Declining Smartphone Market’ – Apple Insider

By Benzinga Newsdesk

December 27, 11:52 AM

https://appleinsider.com/articles/22/12/27/iphone-gains-china-market-share-in-declining-smartphone-market The entire smartphone market in China is getting hit badly, but Apple is gaining marketshare with the iPhone

AAPL

Cantor Fitzgerald Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $33

By Benzinga Newsdesk

March 14, 7:32 AM

Cantor Fitzgerald analyst Charles Duncan maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and raises the price target from $28 to $33.

ACAD

Oppenheimer Downgrades RingCentral to Perform

Related Posts

Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling

Barclays Initiates Coverage On KKR & Co with Overweight Rating, Announces Price Target of $69

‘iPhone Gains China Market Share In Declining Smartphone Market’ – Apple Insider

Cantor Fitzgerald Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $33